Reductions in high-risk drug use behaviors among participants in the Baltimore Needle Exchange Program

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 16, Issue 5, 1997, Pages 400-406

  Vlahov, David ^a   Junge, Benjamin ^a   Brookmeyer, Ronald ^a   Cohn, Sylvia ^a   Riley, Elise ^a   Armenian, Haroutune ^a   Beilenson, Peter ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b BALTIMORE CITY HEALTH DEPARTMENT   (United States)

Author keywords

HIV; Injection drug use; Needle exchange program; Prevention; Substance abuse

Indexed keywords

COCAINE; DIAMORPHINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; BEHAVIOR; COUNSELING; DRUG ABUSE; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; INJECTION; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRIORITY JOURNAL; SUBSTANCE ABUSE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031473319     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199712150-00014     Document Type: Article

References (20)

1. Alcabes P, Friedland GH. Injection drug use and human immunodeficiency virus infection. Clin Infect Dis 1995;20:1467-79.
2. Levine OS, Vlahov D, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injecting drug users: Association with drug injection patterns. Am J Epidemiol 1995;142:331-41.
3. van Ameijden EJC, van den Hoek JAR, Mientjes FHC, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol 1993;9:255-62.
4. U.S. General Accounting Office. Needle exchange programs: research suggests promise as an AIDS prevention strategy (GAO/HRD-93-60). Washington, DC: U.S. Government Printing Office, 1993.
5. Lurie P, Reingold AL, Bowser B, et al. The public health impact of needle exchange programs in the United States and abroad. San Francisco, California: University of California Press, 1993.
6. Normand J, Vlahov D, Moses LE, eds. Preventing HIV transmission: the role of sterile needles and bleach. Washington D.C.: National Academy Press, 1995.
7. Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injecting drug users participating in the Tacoma syringe exchange program. Am J Public Health 1995;85:1531-7.
8. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996;348:987-91.
9. Kaplan EH, O Keefe E. Let the needles do the talking. Evaluating the New Haven needle exchange. Interfaces 1993;23:7-26.
10. Marmor M, Des Jarlais DC, Cohen H, et al. Risk Factors for injection with human immunodeficiency virus among drug abusers in New York City. AIDS 1987;1:39-44.
11. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV injection in intravenous drug users in San Francisco. JAMA 1989;261:561-5.
12. Koester SR, Booth R, Wiebel W. The risk of HIV transmission from sharing water, drug-mixing containers and cotton filters among intravenous drug users. Int J Drug Policy 1990;1:28-30.
13. Grund JP, Kaplan CD, Adriaans NFP, et al. Drug sharing and HIV transmission risks: the practice of frontloading in the Dutch injecting drug using population. J Psychoactive Drugs 1991;23:1-10.
14. Latkin C, Mandell W, Vlahov D, Oziemkowska M, Knowlton A, Celentano DD. My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol 1994;22: 415-30.
15. Oliver KJ, Friedman SR, Maynard H, Magnuson L, Des Jarlais DC. Impact of a needle exchange program on potentially infectious syringes in public places. J Acquir Immune Defic Syndr 1992;5: 531.
16. Armitage P. Statistical methods in medical research. New York: John Wiley & Sons, 1971.
17. Vlahov D, Brookmeyer RS. The evaluation of needle exchange programs [editorial]. Am J Public Health 1994;84:1889-91.
18. Samuels J, Vlahov D, Anthony JC, Chaisson RE. Measurement of risk behaviors among intravenous drug users. Br J Addict 1992; 87:417-28.
19. Hagan H, Des Jarlais DC, Purchase D, Friedman SR, Reid TR, Bell TA. An interview study of participants in the Tacoma, Washington syringe exchange. Addiction 1993;88:1691-7.
20. Junge B, Valente T, Vlahov D. Syringe acquisition dynamics: Predicting retention of clients in the Baltimore needle exchange program [abstract F-16]. Paper presented at the Society for Applied Anthropology Annual Meeting, Baltimore, 1996.